Delhi court declares 4 promoters of Sterling Biotech as fugitive economic offenders
New Delhi: A Delhi court on Monday declared four directors of a Gujarat pharma firm, Sterling Biotech Ltd (SBL), "fugitive economic offenders" in a Rs 8,100-crore bank fraud case.
Additional Sessions Judge Dharmender Rana passed the order on a plea filed by the Enforcement Directorate (ED).
"I have no hesitation in observing that this court is satisfied that the Petitioner has successfully pleaded and proved that the Respondents herein are fugitive economic offenders.
"It is hereby declared that accused Nitin Jayantilal Sandesara, Chetan Jayantilal Sandesara, Dipti Chetan Jayantilal Sandesra and Hiteshkumar Narendrabhai Patel are fugitive economic offenders," the judge said.
Additional Solicitor General S V Raju, appearing for the ED, had told the court that accused had fled from the country and were evading the process of law to face criminal prosecution.
The agency, also represented by special prosecutor Nitesh Rana, had moved the plea seeking to declare the accused as fugitive economic offenders and for confiscation of their properties.
The prosecutor, however, told the court during the argument that they wanted to confine their prayer only to the extent that the accused be declared fugitive economic offenders.
In its order, the judge said that the ED may reapproach the court for initiation of confiscation proceedings.
The charge sheet, filed under the various provisions of the Prevention of Money Laundering Act, accused the company of taking loans from a consortium led by Andhra Bank which had turned into non-performing assets (NPAs) or bad loans.
According to the ED, the accused manipulated figures in the balance sheets of their flagship companies and induced banks to sanction higher loans.
It said the investigation has revealed that 249 companies have been incorporated in the country by promoters of Sterling Biotech out of which 200 firms were found to be ''benami'' entities used to siphon off loan funds obtained from various banks.
Read also: Sterling Biotech Rs 8100-crore bank loan fraud case reassigned to same judge who recused earlier
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.